Patents by Inventor Basem Abdallah

Basem Abdallah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160355804
    Abstract: There is provided nucleic acids (mir-138Antimirs) for use in treating or preventing bone loss in a patient. Also there is provided a method for reducing the levels of endogenous mir-138 in a cell.
    Type: Application
    Filed: January 7, 2016
    Publication date: December 8, 2016
    Inventors: Moustapha KASSEM, Basem ABDALLAH, Hanna TAIPALEENMAEKI, Sakari KAUPPINEN, Tilde ESKILDSEN, Jan STENVANG
  • Patent number: 9273006
    Abstract: There is provided compounds for treating bone loss diseases and for preventing bone loss. Specifically the present invention relates to compounds, preferable isoquinolene derivatives.
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: March 1, 2016
    Assignees: SYDDANSK UNIVERSITET, REGION SYDDANMARK
    Inventors: Abbas Jafari, Li Chen, Moustapha Kassem, Basem Abdallah
  • Publication number: 20150126548
    Abstract: There is provided compounds for treating bone loss diseases and for preventing bone loss. Specifically the present invention relates to compounds, preferable isoquinolene derivatives.
    Type: Application
    Filed: May 3, 2013
    Publication date: May 7, 2015
    Inventors: Abbas Jafari, Li Chen, Moustapha Kassem, Basem Abdallah
  • Publication number: 20140194491
    Abstract: There is provided nucleic acids (mir-138 Antimirs) for use in treating or preventing bone loss in a patient. Also there is provided a method for reducing the levels of endogenous mir-138 in a cell.
    Type: Application
    Filed: June 11, 2012
    Publication date: July 10, 2014
    Applicant: SYDDANSK UNIVERSITET
    Inventors: Moustapha Kassem, Basem Abdallah, Hanna Taipaleenmaeki, Sakari Kauppinen, Tilde Eskildsen, Jan Stenvang